Related Experiment Video
Updated: May 4, 2026
04:56
Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
1.9K
Shigella vaccine development: prospective animal models and current status
Yeon-Jeong Kim, Sang-Gu Yeo, Jae-Hak Park
1Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Hyoja 2-dong, Chuncheon-si, Gangwon-do, South Korea 200-701. hjko@kangwon.ac.kr.
Current Pharmaceutical Biotechnology
|December 31, 2013
Summary
Developing a Shigella vaccine is crucial due to drug-resistant strains. Promising vaccine candidates and animal models, including a new mouse model, are reviewed to combat shigellosis.
Area of Science:
- * Infectious Diseases
- * Vaccinology
- * Microbiology
Background:
- * Shigella bacteria cause dysenteric diarrhea, posing significant risks, especially to vulnerable populations in developing nations.
- * Antibiotic resistance in Shigella necessitates alternative control strategies like vaccination.
- * Current vaccine development faces challenges, including the lack of ideal animal models and incomplete understanding of Shigella's pathology and immunology.
Purpose of the Study:
- * To review promising Shigella vaccine candidates.
- * To discuss available animal models for shigellosis research, highlighting a new murine model.
- * To provide a comprehensive overview of the current landscape of Shigella vaccine development.
Main Methods:
- * Literature review of existing Shigella vaccine research.
- * Analysis of various vaccine types (live attenuated, killed whole cells, conjugated, subunit).
- * Evaluation of animal models used in shigellosis studies, including limitations and a novel murine model.
Main Results:
- * Several vaccine candidates across different platforms show promise.
- * A new murine model using peritoneal infection with virulent S. flexneri 2a is a potentially valuable tool.
- * Challenges in Shigella vaccine development include cost, stability, safety, and immunogenicity.
Conclusions:
- * Despite obstacles, diverse Shigella vaccine candidates are under development.
- * Improved animal models are critical for advancing vaccine efficacy studies.
- * Successful Shigella vaccine development requires addressing practical considerations alongside scientific challenges.
